PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

TRANSURETHRAL VAPORESECTION OF THE PROSTATE (TUVRP) ? IMPROVED GOLD STANDARD?
Article published in Urologia Polska 1998/51/3.

authors

Wojciech Husiatyński, Wojciech Pypno
Klinika Urologii CMKP w Warszawie
Kierownik Kliniki: prof. dr hab. med. A. Borówka

keywords

prostate benign prostatic hyperplasia transurethral resection vaporesection

summary

Objective. The purpose of this prospective study was to value the safety and
the efficacy of transurethral vaporesection of the prostate (TUVRP), and to analise
the initially evaluation of permanent therapeutic effect.
Material and methods. From January to November 1997, 47 TUVRP were
performed (mean age 68.7). Preoperative IPSS ranged between 8 and 32 (mean
22.4), QoL - 3 and 6 (mean4.4), Qmax - 0 and 14 ml/s (mean 6.85 ml/s), Qavc -
0 and 9 ml/s (mean 3.7 ml/s), Rv - 20 and 540 ml (mean 172 ml). We used
resectoscope of 24 french sheat with the new vapor-cut loop, an electronic
coagulator Autocon 300 at a power 200 W. Surgical techni±ue, border of resection
was like standard TURP, speed of electrode slow (one third the speed of a TURP).
Results. No patient re±uired blood transfusion, or had TUR syndrome. The
catheter had been removed mainly the following day and almost all patients
voided spontaneusly.
Conclusions. Vaporesection of prostate seems to bee a safe techin±ue for
treatment of Symptomatic BPH. The follow-up of 6 months shows that TUVRP
improves significantly measure parameters of miction (IPSS, QoL, Qmax, Qave, Rv),
but to determine the permanent therapeutic effect, further follow-up evaluation
is needed.

references

  1. [1] Bohlen, D., Eberle, J., Fuegen, M., Studer, U. E.: Der Einsatz des hoch
  2. intenswen Ultraschalls (HIFU) im klinischen Alltag. Ergebnisse und mógliche
  3. Indikationeti. Urologe A 1996, 1 (supl), 95.
  4. [2] Borkowski, A., Borówka, A.: Choroby gruczołu krokowego. PZWL, War-
  5. szawa 1997, 180-189.
  6. [3] E vans, R.: THE VP: Initial experiens with long-term follow-up. Urol. Trends 1996,
  7. 1,1-5.
  8. [4] Hartung, R., Fastenmeier, K., L*eyh, H.: VerbesserungderHochfrequenz-Chirur-
  9. gie bei der TURP-Einsatz der Band-Elektrode. Urologe A1996,1 (supl.), 94.
  10. [5] Kohrmann, K. U., Michel, M. S., Weber, A., Alken, R: Vapor-Cut - Eine
  11. neue HF-Elektrode zur Resektion der Prostata im Vergleich zu Standardschlinge und
  12. Rollerball. Urologe A1996,1 (supl.), 95.
  13. [6] Manseck, A., Leike, S., Wirth, M.: Die transurethrale Vaporesektion der Prosta-
  14. ta (TUVRP). Urologe A1996,1 (supl.), 95.
  15. [7] Minardi, D., Baldassari, M., Caraceni, E. i wsp.: Transurethral needle abla-
  16. tion (T. U.N.A.) in benign prostatic hypertrophy. Eur. Urol. 1996,2 (supl.), 378.
  17. [8] Narayan, R, Tewari, A., Garzoho, M, Parramore, H. i wsp.: Transurethral
  18. Mapor-Trode electrovaporization of the prostate: physical principles, techni±ue, and
  19. results. Urology 1996,47,505-510.
  20. [9] Pypno, W., Husiatyński, W.: Miejsce laseroterapii w leczeniu łagodnego rozro-
  21. stu stercza. Urol. Pol., 1997,50/2a, 96.
  22. [10] Rassler, J., Nietzsch, D.^ Stolzenburg, J. U., Dorschner, W.: Vaporisation
  23. der Prostata-Klinische Ergebnisse. Urologe A, 1996,1 (supl.) 94.
  24. [11] Vallancien, G., Faure, F., Veillon, B., Guilloneau, B.:Anewtoolfor transu-
  25. rethral resection of the prostate: the Vapor Cut. Eur. Urol. 1996,2 (supl), 221.